prednisone has been researched along with Macrophage Activation Syndrome in 7 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Macrophage Activation Syndrome: A serious complication of childhood systemic inflammatory disorders that is thought to be caused by excessive activation and proliferation of T-LYMPHOCYTES and MACROPHAGES. It is seen predominantly in children with systemic onset JUVENILE IDIOPATHIC ARTHRITIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic juvenile idiopathic arthritis (sJIA) is characterized by a large range of extra-articular manifestations in addition to joint inflammation." | 2.52 | Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome. ( Wagner-Weiner, L, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnet, A | 1 |
| Bossard, C | 1 |
| Gabellier, L | 1 |
| Rohmer, J | 1 |
| Laghmari, O | 1 |
| Parrens, M | 1 |
| Sarkozy, C | 1 |
| Dulery, R | 1 |
| Roland, V | 1 |
| Llamas-Gutierrez, F | 1 |
| Oberic, L | 1 |
| Fornecker, LM | 1 |
| Bounaix, L | 1 |
| Villemagne, B | 1 |
| Szablewski, V | 1 |
| Choquet, S | 1 |
| Bouabdallah, K | 1 |
| Traverse-Glehen, A | 1 |
| Mohty, M | 1 |
| Sanhes, L | 1 |
| Houot, R | 1 |
| Gastinne, T | 1 |
| Leux, C | 1 |
| Le Gouill, S | 1 |
| Wagner-Weiner, L | 1 |
| Moling, O | 1 |
| Piccin, A | 1 |
| Tauber, M | 1 |
| Marinello, P | 1 |
| Canova, M | 1 |
| Casini, M | 1 |
| Negri, G | 1 |
| Raffeiner, B | 1 |
| Binazzi, R | 1 |
| Gandini, L | 1 |
| Vecchiato, C | 1 |
| Rimenti, G | 1 |
| Billio, A | 1 |
| Barešić, M | 1 |
| Janka, GE | 1 |
| Gjadrov-Kuveždić, K | 1 |
| Zekan, Š | 1 |
| Anić, B | 1 |
| Hone, N | 1 |
| Donnelly, C | 1 |
| Houk, JB | 1 |
| Mina, R | 1 |
| Zulian, F | 1 |
| Piccinini, P | 1 |
| Martini, G | 1 |
| Jorini, M | 1 |
| de Benedictis, FM | 1 |
| Araujo, DB | 1 |
| Borba, EF | 1 |
| Silva, CA | 1 |
| Campos, LM | 1 |
| Pereira, RM | 1 |
| Bonfa, E | 1 |
| Shinjo, SK | 1 |
1 review available for prednisone and Macrophage Activation Syndrome
| Article | Year |
|---|---|
Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.
Topics: Antirheumatic Agents; Arthralgia; Arthritis, Juvenile; Child; Cyclosporine; Drug Therapy, Combinatio | 2015 |
6 other studies available for prednisone and Macrophage Activation Syndrome
| Article | Year |
|---|---|
Clinical presentation, outcome, and prognostic markers in patients with intravascular large B-cell lymphoma, a lymphoma study association (LYSA) retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Do | 2022 |
Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Impla | 2016 |
Visceral leishmaniasis triggering (mimicking) macrophage activation syndrome in a patient with adult onset Still disease.
Topics: Adult; Bone Marrow; Cyclosporine; Diagnosis, Differential; Humans; Leishmaniasis, Visceral; Macropha | 2016 |
Macrophage Activation Syndrome in Scleroderma.
Topics: Adult; Diagnosis, Differential; Female; Glucocorticoids; Humans; Lymphohistiocytosis, Hemophagocytic | 2017 |
Macrophage activation syndrome as trigger event for systemic lupus erythematosus in children.
Topics: Anti-Inflammatory Agents; Child; Female; Humans; Lupus Erythematosus, Systemic; Macrophage Activatio | 2009 |
Alveolar hemorrhage: distinct features of juvenile and adult onset systemic lupus erythematosus.
Topics: Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; Child; Dyspnea; Female; Hemoglobins; Hemop | 2012 |